Abner Herrman & Brock LLC Bristol Myers Squibb CO Transaction History

Abner Herrman & Brock LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 05, 2023	SELL	$63.71 - $70.74 $13.4 Million - $14.9 Million	-210,264 Reduced 98.35%	3,520 $225,000
Q1 2023 Apr 13, 2023	SELL	$65.71 - $74.53 $372,772 - $422,808	-5,673 Reduced 2.59%	213,784 $14.8 Million
Q4 2022 Jan 04, 2023	BUY	$68.48 - $81.09 $108,609 - $128,608	1,586 Added 0.73%	219,457 $15.8 Million
Q3 2022 Oct 06, 2022	BUY	$0.13 - $76.84 $158 - $93,744	1,220 Added 0.56%	217,871 $15.5 Million
Q2 2022 Jul 13, 2022	BUY	$72.62 - $79.98 $15.7 Million - $17.3 Million	216,651 New	216,651 $16.7 Million
Q4 2020 Jan 12, 2021	SELL	$57.74 - $65.43 $244,933 - $277,554	-4,242 Closed	0 $0
Q3 2020 Oct 08, 2020	SELL	$57.43 - $63.64 $3.64 Million - $4.03 Million	-63,383 Reduced 93.73%	4,242 $256,000
Q2 2020 Jul 10, 2020	BUY	$54.82 - $64.09 $1,315 - $1,538	24 Added 0.04%	67,625 $3.98 Million
Q1 2020 Apr 09, 2020	SELL	$46.4 - $67.43 $23,200 - $33,715	-500 Reduced 0.73%	67,601 $3.77 Million
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $3.35 Million - $4.37 Million	68,101 New	68,101 $4.37 Million
Q2 2018 Jul 06, 2018	SELL	$50.53 - $62.98 $441,379 - $550,130	-8,735 Closed	0 $0
Q1 2018 Apr 06, 2018	SELL	$59.92 - $68.98 $11,984 - $13,796	-200 Reduced 2.24%	8,735 $553,000
Q4 2017 Jan 05, 2018	BUY	$59.94 - $65.35 $38,241 - $41,693	638 Added 7.69%	8,935 $548,000
Q3 2017 Oct 06, 2017	BUY	$55.23 - $63.74 $458,243 - $528,850	8,297	8,297 $529,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

Stay updated on Abner Herrman & Brock LLC with notifications on news.